OSRX Inc.

Form 483 issued September 23, 2021 · Missoula, Montana

Inspection
Sep 15 – Sep 23, 2021
Observations
1
Pages
2
FEI number
3014549846

In short: On September 23, 2021, FDA issued a Form 483 with 1 observation to OSRX Inc. in Missoula, Montana (FEI 3014549846) after an inspection that ran Sep 15 – Sep 23, 2021. The investigators were Kenneth O. Gee and Sangeeta M. Khurana. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.113 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Your firm's current laminar air flow studies (smoke studies) of the ISO 5 (b)(4) Laminar Airflow…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at OSRX Inc.?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected OSRX Inc.?

Kenneth O. Gee and Sangeeta M. Khurana are named on this Form 483, for the inspection of Sep 15 – Sep 23, 2021. Each investigator has a profile showing what they cite most.

When was OSRX Inc. inspected by FDA?

The inspection ran Sep 15 – Sep 23, 2021, and the Form 483 is dated September 23, 2021.

How do I get the full Form 483 for OSRX Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free